Financials
- Fiscal year
- 2023
- Total assets
- €1.8m
- Loss
- -€144,701
- Solvency
- 89.7%
Total assets▼ 4.3%
Net result
20182023
CLOSSON
ActiveSummary
The computed 12-month bankruptcy probability of CLOSSON is 5.2% (elevated). For CLOSSON, at least two filing cycles of the annual accounts are missing. The 2023 annual accounts show equity of €1.6m and a net result of -€144,701. Equity is growing by ~13.8% per year across the filed fiscal years. Its solvency ranks better than 95% of 6290 sector peers (fiscal year 2023). The company has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals.
Overview
Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
€1.8mtotal assets 2023
- Equity
- €1.6m
- Loss
- -€144,701
Financial health
- Bankruptcy chance 12 m
- 5.2%
2023 figures too old to score
Structure
- Holdings
- 1
Accounts 431 d overdue0 of 4 deeds read
Signals- Figures for FY 2023 (filed 26-11-2024)- 2 financial years not filed after the legal deadline; latest accounts 118 days late; 2 of the last 3 late- Two or more financial years not filed- Filed more than 90 days late+ Equity €1.6m (89.7% of total assets)+ Founded in 2012Show the evidence
Checked score
No current score
Figures too old
The available figures for FY 2023 are too old to assess current financial health.
Bankruptcy probability: Elevated
Filing: At least two filing cycles are missing
Financial strength, FY 2023 · tick = 2022
Average
Solvency
100=
equity 89.7% of total assets
Liquidity
52-48
short-term debt 8.8% · cash 1.5%
Profitability
9-5
return on assets -8.1%
Bankruptcy probability, 12 months
5.2%
Elevated
0%0.5%1.5%4%10%≥ 25%
About 5 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.6%lowest value
12-2024: 1.1%▲ +75.3% vs 11-2024
01-2025: 1.1%▼ -0.6% vs 12-2024
02-2025: 1.1%● 0.0% vs 01-2025
03-2025: 1.1%▼ -0.2% vs 02-2025
04-2025: 1.1%▲ +2.5% vs 03-2025
05-2025: 1.1%▼ -1.0% vs 04-2025
06-2025: 1.1%▼ -0.3% vs 05-2025
07-2025: 1.3%▲ +12.8% vs 06-2025
08-2025: 1.5%▲ +15.7% vs 07-2025
09-2025: 1.4%▼ -6.1% vs 08-2025
10-2025: 1.9%▲ +39.0% vs 09-2025
11-2025: 1.9%▼ -3.1% vs 10-2025
12-2025: 2.4%▲ +30.3% vs 11-2025
01-2026: 4.2%▲ +70.5% vs 12-2025
02-2026: 4.2%● 0.0% vs 01-2026
03-2026: 4.2%▲ +1.8% vs 02-2026
04-2026: 3.8%▼ -9.2% vs 03-2026
05-2026: 3.8%● 0.0% vs 04-2026
06-2026: 3.8%● 0.0% vs 05-2026
07-2026: 3.8%● 0.0% vs 06-2026
08-2026: 5.2%▲ +34.6% vs 07-2026highest value
09-2026: 5.2%● 0.0% vs 08-2026highest value
10-2026: 5.2%● 0.0% vs 09-2026highest value
- Figures for FY 2023 (filed 26-11-2024) raises the probability
- 2 financial years not filed after the legal deadline; latest accounts 118 days late; 2 of the last 3 late raises the probability
- Equity €1.6m (89.7% of total assets) lowers the probability
- Founded in 2012 lowers the probability for this profile
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-12-2024, 2 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 10 filingsPosition against the passed deadline
31-12-2024 close31-07-2025 deadline05-10-2026 today
raises risk · Filed more than 90 days late
The financial year that closed on 31-12-2023 was due by 31-07-2024 and was filed on 26-11-2024, 118 days past the deadline. Measured on financial year 2023: companies more than 90 days late are in an abnormal legal state today in 5.61% of cases, against 1.66% across all filers.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
not filed
2023
118 d late
2022
87 d late
2021
16 d early
2020
15 d early
2019
82 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 5 accounts on average 51 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.
Checked, nothing found (1)
- Annual accounts filedfiscal year 2023 · full…
- Weakest financial yearnet -€144,701
- Annual accounts filedfiscal year 2022 · micro…
Key points
- Risk: Accounts not fileddeadline was 31-07-2025 431 d late View
- Caution: Result fell in 2023from -€76,435 to -€144,701 ▼ 89.3% View
- Caution: Among the weakest 10% on net resultsector median €91,510 · 6,299 companies -€144,701 View
- Caution: 2 loss-making years in a rowloss fiscal year 2023 -€144,701 View
By topic
Network & group
- Subsidiaries
- 1
1 subsidiary
Timeline
- Events
- 15
- Since
- 2015
- 26-11-2024Annual accounts filed
- 31-12-2023Weakest financial year
- 26-10-2023Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460
- Founded
- 09-01-2012
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.